{"code":"E08.3599","type":"code","title":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, unspecified eye","codeAlso":[],"includes":[],"modern_v":"official26","codeFirst":["the underlying condition, such as:","congenital rubella (P35.0)","Cushing's syndrome (E24.-)","cystic fibrosis (E84.-)","malignant neoplasm (C00-C96)","malnutrition (E40-E46)","pancreatitis and other diseases of the pancreas (K85-K86.-)"],"excludes1":["drug or chemical induced diabetes mellitus (E09.-)","gestational diabetes (O24.4-)","neonatal diabetes mellitus (P70.2)","postpancreatectomy diabetes mellitus (E13.-)","postprocedural diabetes mellitus (E13.-)","secondary diabetes mellitus NEC (E13.-)","type 1 diabetes mellitus (E10.-)","type 2 diabetes mellitus (E11.-)"],"excludes2":[],"isBillable":true,"fyEffectivity":{"fy2026":true,"fy2027":true,"billableFy2026":true,"billableFy2027":true},"inclusionTerms":[],"useAdditionalCode":["code to identify control using:","injectable non-insulin antidiabetic drugs (Z79.85)","insulin (Z79.4)","oral antidiabetic drugs (Z79.84)","oral hypoglycemic drugs (Z79.84)"],"clinicalDefinition":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, unspecified eye is a billable ICD-10-CM diagnosis code (E08.3599). Excludes1 (not coded here): drug or chemical induced diabetes mellitus (E09.-); gestational diabetes (O24.4-); neonatal diabetes mellitus (P70.2); postpancreatectomy diabetes mellitus (E13.-); postprocedural diabetes mellitus (E13.-); secondary diabetes mellitus NEC (E13.-); type 1 diabetes mellitus (E10.","officialDefinition":"Diabetes mellitus due to underlying condition with proliferative diabetic retinopathy without macular edema, unspecified eye is a billable ICD-10-CM diagnosis code (E08.3599). Excludes1 (not coded here): drug or chemical induced diabetes mellitus (E09.-); gestational diabetes (O24.4-); neonatal diabetes mellitus (P70.2); postpancreatectomy diabetes mellitus (E13.-); postprocedural diabetes mellitus (E13.-); secondary diabetes mellitus NEC (E13.-); type 1 diabetes mellitus (E10.-); type 2 diabetes mellitus (E11.-). Code first: the underlying condition, such as:; congenital rubella (P35.0); Cushing's syndrome (E24.-); cystic fibrosis (E84.-); malignant neoplasm (C00-C96); malnutrition (E40-E46); pancreatitis and other diseases of the pancreas (K85-K86.-). Use additional code: code to identify control using:; injectable non-insulin antidiabetic drugs (Z79.85); insulin (Z79.4); oral antidiabetic drugs (Z79.84); oral hypoglycemic drugs (Z79.84). 7th character: One of the following 7th characters is to be assigned to codes in subcategory E08.35 to designate laterality of the disease:.","seventhCharacterInstructions":["One of the following 7th characters is to be assigned to codes in subcategory E08.35 to designate laterality of the disease:"],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":"","noteProvenance":{"drug or chemical induced diabetes mellitus (E09.-)":"E08","gestational diabetes (O24.4-)":"E08","neonatal diabetes mellitus (P70.2)":"E08","postpancreatectomy diabetes mellitus (E13.-)":"E08","postprocedural diabetes mellitus (E13.-)":"E08","secondary diabetes mellitus NEC (E13.-)":"E08","type 1 diabetes mellitus (E10.-)":"E08","type 2 diabetes mellitus (E11.-)":"E08","the underlying condition, such as:":"E08","congenital rubella (P35.0)":"E08","Cushing's syndrome (E24.-)":"E08","cystic fibrosis (E84.-)":"E08","malignant neoplasm (C00-C96)":"E08","malnutrition (E40-E46)":"E08","pancreatitis and other diseases of the pancreas (K85-K86.-)":"E08","code to identify control using:":"E08","injectable non-insulin antidiabetic drugs (Z79.85)":"E08","insulin (Z79.4)":"E08","oral antidiabetic drugs (Z79.84)":"E08","oral hypoglycemic drugs (Z79.84)":"E08"},"hcc":{"mapped":true,"model":"CMS-HCC V28","paymentYear":"2026","categories":[{"hcc":"298","label":"Severe Diabetic Eye Disease, Retinal Vein Occlusion, and Vitreous Hemorrhage","family":"","suppresses":[]},{"hcc":"37","label":"Diabetes with Chronic Complications","family":"Diabetes","suppresses":[{"hcc":"38","label":"Diabetes with Glycemic, Unspecified, or No Complications"}]}],"otherModels":[{"model":"CMS-HCC V22","hcc":"122"},{"model":"CMS-HCC V22","hcc":"18"},{"model":"RxHCC V08","hcc":"30"}]}}